Vaccine Development Partners

CARB-X accelerates global antibacterial innovation by supporting the development of new antibiotics and other life-saving products to combat the most dangerous drug-resistant bacteria. Our portfolio represents the world’s most scientifically diverse, early development pipeline of new antibiotics, vaccines, rapid diagnostics, and other products to prevent, diagnose and treat life-threatening bacterial infections.

Vaxxinova US

Vaxxinova US develops, manufactures and sells veterinary vaccines based upon proprietary metal transport receptor protein technology (SRP). Vaxxinova US and Syntiron have worked together on vaccine development to improve OneHealth since 2004.

National Institutes of Health (NIH/NIAID)

 Since 2006, Syntiron has been awarded six Small Business Innovation Research grants from the National Institute for Allergy and Infectious Disease (NIAID) for the research and development of vaccines against E. coli, Salmonella spp.Staphylococcus aureus and Yersinia pestis.

US Department of Defense/DTRA

In 2009, Syntiron received a $4.1 million contract from the US Defense Threat Reduction Agency (DTRA) for the development of vaccines to protect against three potential bacterial biowarfare agents –  Bacillus anthracis (anthrax), Yersinia pestis (plague) and Burkholderia pseudomallei (melioidosis).

Latham Biopharm Group

Latham Biopharm Group unites teams and technology in the biotechnology arena to drive products toward commercialization. LBG has worked with Syntiron since 2018 on preclinical development, manufacturing, regulatory and clinical development.

Minnesota Medical Alley

Syntiron is proud to be a member of Medical Alley, a Minnesota-based trade organization with nearly 700 member organizations. Medical Alley affords Syntiron significant benefits such as educational seminars, networking opportunities, and advocacy in legislative and regulatory matters at local, state and federal levels.

Partner with us.


Syntiron actively seeks partnerships that contribute to the advancement of human vaccines. For more information on our project and partnership opportunities, please contact us.


1000 Westgate Drive
St Paul MN 55114